Pericardial effusion in patients with COVID-19: case series.
François SauerCharlotte DagrenatPhilippe CouppieGaelle JochumPierre LeddetPublished in: European heart journal. Case reports (2020)
Presumably rare, we reported three cases of pericardial effusions (PEs) occurring in a single cardiology centre. There is a higher incidence of COVID-19-related cardiac diseases such as pericarditis that can manifest as a minimal PE to a cardiac tamponade, which should result in a higher awareness of cardiologists. A systematic measure of the high-sensitivity troponin kinetic in patients affected by COVID-19 could be interesting in order to screen for potential myocarditis. Any unexplained haemodynamic failure or increased cardiac biomarkers should make the medical team search for myopericarditis by a transthoracic echocardiography.
Keyphrases
- left ventricular
- coronavirus disease
- sars cov
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- computed tomography
- risk factors
- pulmonary hypertension
- heart failure
- high throughput
- quality improvement
- climate change
- human health
- cardiac surgery
- atrial fibrillation
- patient reported
- single cell